Non-sirtuin histone deacetylases in the control of cardiac aging

Journal of Molecular and Cellular Cardiology
Bradley S Ferguson, Timothy A McKinsey

Abstract

Histone deacetylases (HDACs) catalyze the removal of acetyl-groups from lysine residues within nucelosomal histone tails and thousands of non-histone proteins. The 18 mammalian HDACs are grouped into four classes. Classes I, II and IV HDACs employ zinc as a co-factor for catalytic activity, while class III HDACs (also known as sirtuins) require NAD+ for enzymatic function. Small molecule inhibitors of zinc-dependent HDACs are efficacious in multiple pre-clinical models of pressure overload and ischemic cardiomyopathy, reducing pathological hypertrophy and fibrosis, and improving contractile function. Emerging data have revealed numerous mechanisms by which HDAC inhibitors benefit the heart, including suppression of oxidative stress and inflammation, inhibition of MAP kinase signaling, and enhancement of cardiac protein aggregate clearance and autophagic flux. Here, we summarize recent findings with zinc-dependent HDACs and HDAC inhibitors in the heart, focusing on newly described functions for distinct HDAC isoforms (e.g. HDAC2, HDAC3 and HDAC6). Potential for pharmacological HDAC inhibition as a means of treating age-related cardiac dysfunction is also discussed. This article is part of a Special Issue entitled: CV Aging.

References

Mar 31, 2004·Journal of Molecular Biology·Ivan V GregorettiHolly V Goodson
Jul 21, 2006·The New England Journal of Medicine·R Sacha BhatiaPeter P Liu
Jan 16, 2007·Cardiovascular Research·Timothy A McKinsey
Oct 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·A LahmP Gallinari
Jan 4, 2008·Expert Opinion on Drug Safety·Jeff M BerryJoseph A Hill
Mar 1, 2008·Bioorganic & Medicinal Chemistry Letters·Philip JonesChristian Steinkühler
May 13, 2008·Trends in Cell Biology·Agustín Valenzuela-FernándezFrancisco Sánchez-Madrid
Jul 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·R B ParmigianiP A Marks
Sep 6, 2008·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Piper M TreutingWarren C Ladiges
Oct 3, 2008·The Journal of Clinical Investigation·Rusty L MontgomeryEric N Olson
Oct 22, 2008·Current Opinion in Genetics & Development·Vincent T Cunliffe
Nov 13, 2008·The New England Journal of Medicine·Barry M MassieUNKNOWN I-PRESERVE Investigators
Dec 9, 2008·Nature Medicine·Kristina LorenzMartin J Lohse
May 20, 2009·Circulation·Dao-Fu DaiPeter S Rabinovitch
Jan 19, 2010·Journal of Molecular and Cellular Cardiology·Mingyi WangAjay M Shah
Feb 6, 2010·Circulation Research·Erik W Bush, Timothy A McKinsey
Feb 9, 2010·Nature Chemical Biology·James E BradnerRalph Mazitschek
Mar 23, 2010·Experimental Hematology·Erica L Herzog, Richard Bucala
Apr 13, 2010·Trends in Cardiovascular Medicine·Dao-Fu Dai, Peter S Rabinovitch
Apr 13, 2010·Heart Failure Reviews·Guido R Y De MeyerWim Martinet
Jul 10, 2010·Journal of the American Chemical Society·Kyle V ButlerAlan P Kozikowski
Oct 27, 2010·Journal of Molecular and Cellular Cardiology·Katarzyna A CieslikMark L Entman
Nov 27, 2010·Journal of Molecular and Cellular Cardiology·Timothy A McKinsey
Dec 9, 2010·European Heart Journal·Barry A Borlaug, Walter J Paulus
Mar 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Dian J CaoJoseph A Hill
Mar 30, 2011·Molecular and Cellular Biology·Edwin F de ZoetenWayne W Hancock
May 5, 2011·Journal of Molecular and Cellular Cardiology·Douglas D LemonTimothy A McKinsey
Aug 2, 2011·The Journal of Biological Chemistry·Magdalena Karolczak-BayattiG Nicholas Europe-Finner
Aug 3, 2011·The Journal of Biological Chemistry·Zheng SunMitchell A Lazar
Sep 29, 2011·Annual Review of Pharmacology and Toxicology·Timothy A McKinsey
Oct 14, 2011·Current Opinion in Cardiology·Dawn C Scantlebury, Barry A Borlaug
Nov 24, 2012·Biopolymers·Noah A WolfsonCarol A Fierke
Jan 5, 2013·Expert Opinion on Drug Metabolism & Toxicology·Joanna FraczekVera Rogiers
Feb 26, 2013·The Journal of Clinical Investigation·Mathias HohlChristoph Maack
May 24, 2013·Biochemical Society Transactions·Richard D W Kelly, Shaun M Cowley
May 31, 2013·Proceedings of the National Academy of Sciences of the United States of America·Bradley S FergusonTimothy A McKinsey
Jun 29, 2013·Experimental Gerontology·Kumuda C Das, Harish Muniyappa
Sep 28, 2013·Journal of Cardiovascular Pharmacology·Martin M LeWinter, Henk L Granzier

❮ Previous
Next ❯

Citations

Jan 19, 2016·Frontiers in Pharmacology·Ralf Weiskirchen
Apr 15, 2015·Journal of Molecular and Cellular Cardiology·Edward G Lakatta
Apr 20, 2016·European Journal of Pharmacology·Baigalmaa LkhagvaYi-Jen Chen
Aug 16, 2016·Ageing Research Reviews·Alexander M VaisermanAlexander K Koliada
Dec 17, 2016·Molecular Nutrition & Food Research·Luis D GodoyBradley S Ferguson
Jul 29, 2018·Nature Reviews. Cardiology·Natalie A GudeMark A Sussman
Sep 12, 2018·Journal of Cellular Physiology·Samantha S RomanickBradley S Ferguson
Jul 18, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Kan Hui YiewNeal L Weintraub
Jun 5, 2019·Future Medicinal Chemistry·Samantha S Romanick, Bradley S Ferguson
Sep 8, 2020·Journal of Zhejiang University. Science. B·Xiao-He ZhengYue-Liang Shen
May 8, 2016·Clinical Science·Sri N BatchuAndrew Advani
Aug 22, 2018·Nutrients·Levi W Evans, Bradley S Ferguson
Jan 2, 2019·International Journal of Molecular Sciences·Justine Habibian, Bradley S Ferguson
Nov 8, 2018·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Yao WuQijian Yi
Jul 15, 2020·Antioxidants·Hossameldin AbouhishManuela Bartoli
Apr 4, 2021·Cells·Jorge Gutiérrez-CuevasJuan Armendariz-Borunda
Feb 19, 2020·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Daniel J HerrDonald R Menick
Jun 4, 2021·Vascular Health and Risk Management·Claudio NapoliGiuditta Benincasa
Jun 28, 2021·Journal of Molecular and Cellular Cardiology·Jian QinZhihua Wang
May 8, 2021·Aging·Pianpian HuangBenling Qi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Genetics & Epigenetics of Aging

Dozens of genes are implicated in lifespan, and epigenetic changes during aging affect cell function. This feed focuses on the genetics and epigenetics of aging.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Cell Aging

This feed focuses on cellular aging with emphasis on mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.